X-38318909-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2_SupportingPP3
This summary comes from the ClinGen Evidence Repository: NM_001034853.2(RPGR):c.389T>C (p.Phe130Ser) is a missense variant predicted to cause substitution of phenylalanine by serine at amino acid 130. This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives the variant a score of 0.761, which is between the ClinGen X-linked IRD VCEP thresholds of 0.664 to 0.772 and predicts a damaging effect on RPGR function (PP3). The computational splicing predictor SpliceAI gives a delta score of 0.01 for donor loss, which is below the ClinGen X-linked IRD VCEP threshold of >0.2 and does not predict that the variant disrupts RPGR splicing. At least 1 patient with this variant has been diagnosed with X-linked retinopathy, but phenotype details necessary to meet PP4 or include the patient in PS4_Supporting have not been reported (PMID:28863407, PMID:32531858, SCV001162677.1). Another missense variant in the same codon, NM_001034853.2(RPGR):c.389T>G (p.Phe130Cys), has been reported in a patient with X-linked retinopathy (PMID:8817343). However, the present variant has a lower Grantham score (155) than the comparison variant (205), so that the PM5 code cannot be evaluated. In summary, this variant is classified as a variant of uncertain significance for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; PM2_Supporting and PP3. (date of approval 05/16/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA412745161/MONDO:0100437/106
Frequency
Consequence
NM_001034853.2 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 3Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- RPGR-related retinopathyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- primary ciliary dyskinesia-retinitis pigmentosa syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- macular degeneration, X-linked atrophicInheritance: XL Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RPGR | NM_001034853.2 | c.389T>C | p.Phe130Ser | missense_variant | Exon 5 of 15 | ENST00000645032.1 | NP_001030025.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Retinitis pigmentosa Pathogenic:1
- -
Primary ciliary dyskinesia Uncertain:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 130 of the RPGR protein (p.Phe130Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 32531858). ClinVar contains an entry for this variant (Variation ID: 813227). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RPGR protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
RPGR-related retinopathy Uncertain:1
NM_001034853.2(RPGR):c.389T>C (p.Phe130Ser) is a missense variant predicted to cause substitution of phenylalanine by serine at amino acid 130. This variant is absent from hemizygous individuals in gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives the variant a score of 0.761, which is between the ClinGen X-linked IRD VCEP thresholds of 0.664 to 0.772 and predicts a damaging effect on RPGR function (PP3). The computational splicing predictor SpliceAI gives a delta score of 0.01 for donor loss, which is below the ClinGen X-linked IRD VCEP threshold of >0.2 and does not predict that the variant disrupts RPGR splicing. At least 1 patient with this variant has been diagnosed with X-linked retinopathy, but phenotype details necessary to meet PP4 or include the patient in PS4_Supporting have not been reported (PMID: 28863407, PMID: 32531858, SCV001162677.1). Another missense variant in the same codon, NM_001034853.2(RPGR):c.389T>G (p.Phe130Cys), has been reported in a patient with X-linked retinopathy (PMID: 8817343). However, the present variant has a lower Grantham score (155) than the comparison variant (205), so that the PM5 code cannot be evaluated. In summary, this variant is classified as a variant of uncertain significance for RPGR-related retinopathy based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPGR Version 1.0.0; PM2_Supporting and PP3. (date of approval 05/16/2025). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at